外科理论与实践 ›› 2026, Vol. 31 ›› Issue (03): 204-211.doi: 10.16139/j.1007-9610.2026.03.05
收稿日期:2026-04-07
出版日期:2026-06-25
发布日期:2026-08-11
通讯作者:
笪倩:E-mail: dq11848@rjh.com.cn作者简介:作者贡献/Authors’ contributions
阮淼负责资料收集和撰写;费晓春负责审校、提供意见;笪倩负责指导、审查和修订。所有作者均阅读并确认最终稿。
RUAN Miao, FEI Xiaochun, DA Qian(
)
Received:2026-04-07
Online:2026-06-25
Published:2026-08-11
摘要:
乳腺癌是全球女性最常见的恶性肿瘤。近年来,随着人工智能(AI)技术的迅速发展,病理基础大模型在乳腺癌病理诊疗领域展现出巨大潜力。本文从技术架构、临床应用、前沿探索及伦理挑战四个维度,系统阐述乳腺癌数字化病理与AI辅助诊断的应用现状与发展趋势,重点介绍以Virchow、UNI、CONCH为代表的病理基础大模型在乳腺癌组织学分级、HER2精准评分、基因型预测等下游任务中的最新进展,探讨PathChat、SlideSeek等多模态生成式AI系统在推动可解释性诊断方面的突破,并就空间转录组学整合、三维(3D)病理重建等前沿方向进行展望。
中图分类号:
阮淼, 费晓春, 笪倩. 乳腺癌数字化病理与人工智能辅助诊断[J]. 外科理论与实践, 2026, 31(03): 204-211.
RUAN Miao, FEI Xiaochun, DA Qian. Digital pathology and artificial intelligence-assisted diagnosis in breast cancer[J]. Journal of Surgery Concepts & Practice, 2026, 31(03): 204-211.
| [1] | Ivanov V, Khalid U, Gurung J, et al. Use of AI histopathology in breast cancer diagnosis[J]. Medicina(Kaunas), 2025, 61(10):1878. |
| [2] |
Li W, Ye S, Jin Z, et al. Artificial intelligence in digital pathology of breast cancer, new era of practice?[J]. Int J Surg, 2025, 111(11):8270-8283.
doi: 10.1097/JS9.0000000000002953 URL |
| [3] |
Mckelvey B, Torres-Saavedra P A, Li J, et al. Agreement across 10 AI models in assessing HER2 expression in breast cancer whole-slide images[J]. Mod Pathol, 2026, 39(2):100944.
doi: 10.1016/j.modpat.2025.100944 URL |
| [4] |
Niazi M K K, Parwani A V, Gurcan M N. Digital pathology and artificial intelligence[J]. Lancet Oncol, 2019, 20(5):e253-e261.
doi: 10.1016/S1470-2045(19)30154-8 |
| [5] |
Lu MY, Williamson D F K, Chen T Y, et al. Data-efficient and weakly supervised computational pathology on whole-slide images[J]. Nat Biomed Eng, 2021, 5(6):555-570.
doi: 10.1038/s41551-020-00682-w pmid: 33649564 |
| [6] |
Chen R J, Ding T, Lu M Y, et al. Towards a general-purpose foundation model for computational pathology[J]. Nat Med, 2024, 30(3):850-862.
doi: 10.1038/s41591-024-02857-3 pmid: 38504018 |
| [7] |
Vorontsov E, Bozkurt A, Casson A, et al. A foundation model for clinical-grade computational pathology and rare cancers detection[J]. Nat Med, 2024, 30(10):2924-2935.
doi: 10.1038/s41591-024-03141-0 pmid: 39039250 |
| [8] |
Sparano J A, Gray R J, Makower D F, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer[J]. N Engl J Med, 2018, 379(2):111-121.
doi: 10.1056/NEJMoa1804710 URL |
| [9] |
Lu M Y, Chen B, Williamson D F K, et al. A multimodal generative AI copilot for human pathology[J]. Nature, 2024, 634(8033):466-473.
doi: 10.1038/s41586-024-07618-3 |
| [10] | Chen C, Weishaupt L L, Williamson D F K, et al. Evidence-based diagnostic reasoning with multi-agent copilot for human pathology[J]. 2025. |
| [11] |
Wang X, Zhao J, Marostica E, et al. A pathology foundation model for cancer diagnosis and prognosis prediction[J]. Nature, 2024, 634(8035):970-978.
doi: 10.1038/s41586-024-07894-z |
| [12] |
Xu H, Usuyama N, Bagga J, et al. A whole-slide foundation model for digital pathology from real-world data[J]. Nature, 2024, 630(8015):181-188.
doi: 10.1038/s41586-024-07441-w |
| [13] |
Zhou X, Sun L, He D, et al. Knowledge-enhanced pretraining for vision-language pathology foundation model on cancer diagnosis[J]. Cancer Cell, 2026, 44(4):777-791.
doi: 10.1016/j.ccell.2026.01.019 URL |
| [14] |
Kaczmarzyk J R, Van Alsten S C, Cozzo A J, et al. Towards interpretable prediction of recurrence risk in breast cancer using pathology foundation models[J]. NPJ Digit Med, 2026, 9(1):149.
doi: 10.1038/s41746-025-02334-2 |
| [15] | Chen R J, Lu M Y, Williamson D F K, et al. Scaling vision transformers to gigapixel images via hierarchical self-supervised learning[C]. arXiv,2022, 2206:02647. |
| [16] |
Li B, Zhong Y, Xing Z, et al. Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays[J]. J Pathol, 2026, 268(4):460-476.
doi: 10.1002/path.v268.4 URL |
| [17] |
Lu M Y, Chen B, Williamson D F K, et al. A visual-language foundation model for computational pathology[J]. Nat Med, 2024, 30(3):863-874.
doi: 10.1038/s41591-024-02856-4 pmid: 38504017 |
| [18] |
Campanella G, Chen S, Singh M, et al. A clinical benchmark of public self-supervised pathology foundation models[J]. Nat Commun, 2025, 16:3640.
doi: 10.1038/s41467-025-58796-1 |
| [19] |
Xiang J, Wang X, Zhang X, et al. A vision-language foundation model for precision oncology[J]. Nature, 2025, 638(8051):769-778.
doi: 10.1038/s41586-024-08378-w |
| [20] |
Ding T, Wagner S J, Song A H, et al. A multimodal whole-slide foundation model for pathology[J]. Nat Med, 2025, 31(11):3749-3761.
doi: 10.1038/s41591-025-03982-3 |
| [21] | Wang Y H, Chang M H, Tsai H H, et al. Transformer-based HER2 scoring in breast cancer: comparative performance of a foundation and a lightweight model[J]. Diagnostics (Basel), 2025, 15(17):2131. |
| [22] |
Ochi M, Komura D, Ishikawa S. Pathology foundation models[J]. JMA J, 2025, 8(1):121-130.
doi: 10.31662/jmaj.2024-0206 URL |
| [23] |
Frascarelli C, Venetis K, Marra A, et al. Deep learning algorithm on H&E whole slide images to characterize TP53 alterations in breast cancer[J]. Comput Struct Biotechnol J, 2024, 23:4252-4259.
doi: 10.1016/j.csbj.2024.11.037 URL |
| [24] |
Li Y, Xiong X, Liu X, et al. An interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer[J]. PeerJ, 2024, 12:e18098.
doi: 10.7717/peerj.18098 URL |
| [25] |
Karasayar A H D, Kulaç İ, Kapucuoğlu N. Advances in breast cancer care: the role of AI and digital pathology in precision medicine[J]. Eur J Breast Health, 2025, 21(2):93-100.
doi: 10.4274/ejbh.galenos.2025.2024-12-8 pmid: 40028897 |
| [26] | Luan H, Hu T, Hu J, et al. Breast cancer homologous recombination deficiency prediction from pathological images[J]. NPJ Precis Oncol, 2025, 9(1):160. |
| [27] | Sparano J A, Gray R J, Makower D F, et al. Clinical and genomic risk for late breast cancer recurrence and survival[J]. NEJM Evid, 2024, 3(8):EVIDoa2300267. |
| [28] |
Sparano J A, Gray R J, Ravdin P M, et al. Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer[J]. N Engl J Med, 2019, 380(25):2395-2405.
doi: 10.1056/NEJMoa1904819 URL |
| [29] |
Kalinsky K, Barlow W E, Gralow J R, et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer[J]. N Engl J Med, 2021, 385(25):2336-2347.
doi: 10.1056/NEJMoa2108873 URL |
| [30] |
Abdou Y, Barlow W E, Gralow J R, et al. Race and clinical outcomes in HR+/HER2-, node-positive breast cancer in the randomized RxPONDER trial[J]. J Natl Cancer Inst, 2025, 117(5):889-897.
doi: 10.1093/jnci/djae314 URL |
| [31] | Shamai G, Cohen S, Binenbaum Y, et al. Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit[J]. Lancet Oncol, 26,27(4):512-526. |
| [32] |
Boehm K M, El Nahhas O S M, Marra A, et al. Multimodal histopathologic models stratify hormone receptor-positive early breast cancer[J]. Nat Commun, 2025, 16(1):2106.
doi: 10.1038/s41467-025-57283-x |
| [33] |
Gessain G, Lacroix-Triki M. Computational pathology for breast cancer: where do we stand for prognostic applications?[J]. Breast, 2025, 81:104464.
doi: 10.1016/j.breast.2025.104464 URL |
| [34] |
Chen W, Zhang P, Tran T N, et al. A visual-omics foundation model to bridge histopathology with spatial transcriptomics[J]. Nat Methods, 2025, 22(7):1568-1582.
doi: 10.1038/s41592-025-02707-1 |
| [35] |
Song A H, Williams M, Williamson D F K, et al. Analysis of 3D pathology samples using weakly supervised AI[J]. Cell, 2024, 187(10):2502-2520.
doi: 10.1016/j.cell.2024.03.035 pmid: 38729110 |
| [36] |
Marra A, Morganti S, Pareja F, et al. Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives[J]. Ann Oncol, 2025, 36:712-725.
doi: 10.1016/j.annonc.2025.03.006 URL |
| [37] |
Campanella G, Kumar N, Nanda S, et al. Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection[J]. Nat Med, 2025, 31(9):3002-3010.
doi: 10.1038/s41591-025-03780-x |
| [38] |
Lång K, Josefsson V, Larsson A M, et al. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study[J]. Lancet Oncol, 2023, 24(8):936-944.
doi: 10.1016/S1470-2045(23)00298-X URL |
| [1] | 姜锐敏, 刘婷, 张涵, 等. 面部美学人工智能辅助诊断系统的创建与教学应用[J]. 组织工程与重建外科杂志, 2026, 22(3): 330-. |
| [2] | 王烁博, 宋点, 翟国华. 智能防空作战技术的发展现状与展望[J]. 空天防御, 2026, 9(3): 18-25. |
| [3] | 邹君, 吕志伟, 王唯潼. 媒介、主体与算法:AI时代语言实践的MDA新框架研究[J]. 当代外语研究, 2026, 26(3): 137-147. |
| [4] | . 老年骨质疏松患者骨折风险预测:临床预测工具与机器学习技术的研究进展[J]. J Shanghai Jiaotong Univ Sci, 2026, 31(3): 759-770. |
| [5] | . 人工智能辅助全髋关节置换术术前模板规划的准确性:骨盆正位片与RAX采集下肢全长片的比较[J]. J Shanghai Jiaotong Univ Sci, 2026, 31(3): 622-630. |
| [6] | . 深度学习重建1.5-T与3-T颞下颌关节磁共振成像[J]. J Shanghai Jiaotong Univ Sci, 2026, 31(3): 611-621. |
| [7] | 陈倩, 杨斌.
人工智能技术在颅缝早闭症诊疗中的应用进展
|
| [8] | 王豪雨, 朱思吉, 李安琪, 陈小松. 循环肿瘤DNA在乳腺癌精准诊疗中的应用与展望[J]. 外科理论与实践, 2026, 31(03): 212-217. |
| [9] | 徐佳妍, 朱思吉. CDK4/6抑制剂在早期乳腺癌辅助治疗应用的热点问题[J]. 外科理论与实践, 2026, 31(03): 227-233. |
| [10] | 吴春晓, 庞怡, 顾凯, 陈蕾, 吴梦吟, 杨群娣, 施燕. 2002—2021年上海市女性乳腺癌发病和死亡情况分析:基于人群基础的研究[J]. 外科理论与实践, 2026, 31(03): 234-242. |
| [11] | 陈园园, 王杰, 陈方. 同时性双侧乳腺癌的临床病理特征及预后分析[J]. 外科理论与实践, 2026, 31(03): 243-249. |
| [12] | 袁帅, 徐国萍, 杨莉, 史有阳, 魏敏. 单孔乳腔镜辅助胸肌前假体置入对比开放胸肌后假体置入Ⅰ期乳房重建术的回顾性研究[J]. 外科理论与实践, 2026, 31(03): 250-256. |
| [13] | 张婷婷, 黄慧, 孙宏莉. 非结核分枝杆菌实验室诊断的现状和研究进展[J]. 诊断学理论与实践, 2026, 25(03): 249-259. |
| [14] | 卢仁泉, 胡玲. 多组学技术与人工智能融合时代新型肿瘤标志物在肿瘤诊治中的研究进展[J]. 诊断学理论与实践, 2026, 25(03): 278-286. |
| [15] | 陈小松, 沈坤炜. 乳腺外科数字化诊疗体系的构建与方向[J]. 外科理论与实践, 2026, 31(03): 183-184. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||